Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis
Objective Biological therapies and small molecules continue to be evaluated in moderate to
severely active ulcerative colitis, but are often studied in placebo-controlled trials, meaning …
severely active ulcerative colitis, but are often studied in placebo-controlled trials, meaning …
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis
NE Burr, DJ Gracie, CJ Black, AC Ford - Gut, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objective</jats: title>< jats: p> Biological therapies and small
molecules continue to be evaluated in moderate to severely active ulcerative colitis, but are …
molecules continue to be evaluated in moderate to severely active ulcerative colitis, but are …
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis
NE Burr, DJ Gracie, CJ Black, AC Ford - Gut, 2022 - search.proquest.com
Objective Biological therapies and small molecules continue to be evaluated in moderate to
severely active ulcerative colitis, but are often studied in placebo-controlled trials, meaning …
severely active ulcerative colitis, but are often studied in placebo-controlled trials, meaning …
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis.
NE Burr, DJ Gracie, CJ Black, AC Ford - Gut, 2021 - europepmc.org
Biological therapies and small molecules continue to be evaluated in moderate to severely
active ulcerative colitis, but are often studied in placebo-controlled trials, meaning their …
active ulcerative colitis, but are often studied in placebo-controlled trials, meaning their …
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis
NE Burr, DJ Gracie, CJ Black, AC Ford - Gut - pubmed.ncbi.nlm.nih.gov
Objective Biological therapies and small molecules continue to be evaluated in moderate to
severely active ulcerative colitis, but are often studied in placebo-controlled trials, meaning …
severely active ulcerative colitis, but are often studied in placebo-controlled trials, meaning …
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis
NE Burr, DJ Gracie, CJ Black, AC Ford - Gut, 2021 - gut.bmj.com
Objective Biological therapies and small molecules continue to be evaluated in moderate to
severely active ulcerative colitis, but are often studied in placebo-controlled trials, meaning …
severely active ulcerative colitis, but are often studied in placebo-controlled trials, meaning …
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis
NE Burr, DJ Gracie, CJ Black, AC Ford - Gut, 2022 - eprints.whiterose.ac.uk
Objective: Biological therapies and small molecules continue to be evaluated in moderate to
severely active ulcerative colitis, but are often studied in placebo-controlled trials, meaning …
severely active ulcerative colitis, but are often studied in placebo-controlled trials, meaning …